Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 8, 2026, 4:10 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 913–936 of 1,131 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Functional MRI Clear all

Conditions: Depression, Mood Disorders, Depressive Disorder
Interventions: Citalopram; Drug
Lead sponsor: Stanford University; Other
Eligibility: 18 Years to 65 Years
Enrollment: 31 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2009 – 2014
U.S. locations: 1
States / cities: Stanford, California

Conditions: Physician-patient Relationship, Fibromyalgia, Acupuncture Therapy
Interventions: Electroacupuncture Analgesia, Hokanson Rapid Cuff Inflator; Device
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 21 Years to 65 Years
Enrollment: 180 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2024
U.S. locations: 2
States / cities: Charlestown, Massachusetts

Conditions: Episodic Memory, Healthy
Interventions: Transcranial magnetic stimulation; Other
Lead sponsor: Boston College; Other
Eligibility: 18 Years to 35 Years
Enrollment: 41 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: Chestnut Hill, Massachusetts

Conditions: Cannabis
Interventions: iTBS; Device
Lead sponsor: Duke University; Other
Eligibility: 18 Years to 65 Years
Enrollment: 50 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2029
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: ADHD
Interventions: OROS-MPH; Drug
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years to 55 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Multiple Sclerosis
Interventions: Not listed
Lead sponsor: Yale University; Other
Eligibility: 18 Years to 55 Years
Enrollment: 120 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2016
U.S. locations: 1
States / cities: New Haven, Connecticut

Conditions: ST-segment Elevation Myocardial Infarction (STEMI)
Interventions: Cardiac magnetic resonance imaging; Diagnostic Test
Lead sponsor: Samsung Medical Center; Other
Eligibility: Not listed
Enrollment: 324 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2023
U.S. locations: 1
States / cities: Iowa City, Iowa

Conditions: Healthy Volunteers, Substance Use Disorders
Interventions: Not listed
Lead sponsor: National Institute on Drug Abuse (NIDA); NIH
Eligibility: 18 Years and older
Enrollment: 847 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2010
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Chronic Widespread Pain, Stress, Psychological, Stress, Physiological
Interventions: functional Magnetic Resonance Imaging (fMRI), Allostatic Load Composite; Diagnostic Test · Other
Lead sponsor: Boston Children's Hospital; Other
Eligibility: 11 Years to 17 Years
Enrollment: 70 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2026
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Relapsing-Remitting Multiple Sclerosis
Interventions: Glatiramer acetate, (Copaxone®), IFN-β-1a, (Avonex®); Drug
Lead sponsor: Neurognostics; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 48 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2007
U.S. locations: 5
States / cities: Los Angeles, California • Seattle, Washington • Madison, Wisconsin + 1 more

Conditions: Tinnitus, Subjective
Interventions: Transcranial electrical stimulation (tES); Device
Lead sponsor: Northwestern University; Other
Eligibility: 18 Years to 65 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2022
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: No Condition, Focus is Neural Effects of Mindfulness Training on Attention
Interventions: Mindfulness Meditation Training (MMT), Nutrition Education course; Behavioral
Lead sponsor: University of Pennsylvania; Other
Eligibility: 18 Years to 65 Years
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2009
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Tinnitus
Interventions: IV Lidocaine; Drug
Lead sponsor: D. Bradley Welling, MD, PhD; Other
Eligibility: 18 Years and older
Enrollment: 40 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2027
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Mood Disorders, Anxiety Disorders
Interventions: 7T Magnetic Resonance Imaging scanner; Device
Lead sponsor: National Institute of Mental Health (NIMH); NIH
Eligibility: 18 Years to 65 Years
Enrollment: 390 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: Started 2006
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Traumatic Brain Injury, Closed Head Injury, Cognitive Dysfunction
Interventions: Real LED Intervention, Sham LED Intervention; Device
Lead sponsor: Boston VA Research Institute, Inc.; Other
Eligibility: 18 Years to 65 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2023
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Healthy
Interventions: Standard HD-tDCS intervention, Multifocal network targeted HD-tDCS intervention, Functional Magnetic Resonance Imaging (fMRI); Device
Lead sponsor: University of Michigan; Other
Eligibility: 65 Years to 85 Years
Enrollment: 40 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Ann Arbor, Michigan

Conditions: Traumatic Brain Injury, Concussion, Mild, Depressive Symptoms
Interventions: Active: rTMS, Sham: rTMS; Device
Lead sponsor: Henry M. Jackson Foundation for the Advancement of Military Medicine; Other
Eligibility: 18 Years to 64 Years
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2020
U.S. locations: 2
States / cities: Bethesda, Maryland • Fort Belvoir, Virginia

Conditions: Obesity, Overweight
Interventions: Tirzepatide, Placebo, Liraglutide; Drug
Lead sponsor: Eli Lilly and Company; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 114 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2022
U.S. locations: 3
States / cities: Indianapolis, Indiana • Baton Rouge, Louisiana • Baltimore, Maryland

Conditions: Pancreatitis, Diabetes Mellitus
Interventions: Research MRI without administration of intravenous secretin, Research MRI with administration of intravenous secretin, Genetic Sequencing, Blood Tests, Stool Tests, Survey Completion, Endoscopic pancreatic function tests (ePFTs), Secretin; Diagnostic Test · Genetic · Other + 1 more
Lead sponsor: Children's Hospital Medical Center, Cincinnati; Other
Eligibility: 5 Years to 21 Years
Enrollment: 195 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2027
U.S. locations: 1
States / cities: Cincinnati, Ohio

Conditions: Mood Disorder, Neurobehavioral Manifestation, Healthy
Interventions: Not listed
Lead sponsor: National Institute of Mental Health (NIMH); NIH
Eligibility: 8 Years to 55 Years
Enrollment: 300 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2001 – 2017
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Ischemic Stroke
Interventions: HT-3951, Placebo; Drug
Lead sponsor: Dart NeuroScience, LLC; Industry
Eligibility: 21 Years to 85 Years
Enrollment: 61 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2017
U.S. locations: 18
States / cities: Phoenix, Arizona • Scottsdale, Arizona • Downey, California + 15 more

Conditions: Irritable Bowel Syndrome
Interventions: Mindfulness based Stress Reduction Training (MBSR); Behavioral
Lead sponsor: University of California, Los Angeles; Other
Eligibility: 18 Years to 50 Years
Enrollment: 119 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2018
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Post Traumatic Stress Disorder
Interventions: Mindfulness-Based Cognitive Therapy, Muscle Relaxation Therapy; Behavioral
Lead sponsor: Ohio State University; Other
Eligibility: 18 Years to 72 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2023
U.S. locations: 2
States / cities: Ann Arbor, Michigan • Columbus, Ohio

Conditions: Childhood Cancer
Interventions: Cardiac 3D MRI; Procedure
Lead sponsor: Majd Makhoul; Other
Eligibility: 8 Years to 26 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2016
U.S. locations: 2
States / cities: Lexington, Kentucky

Search by objective public record fields.

Functional MRI Before and After Treatment for Depression

Brain Mechanisms of Psychosocial Aspects of Acupuncture Therapy

Causal Role of Brain Networks in Episodic Memory

Transcranial Magnetic Brain Stimulation to Reduce Cannabis Use in Heavy Cannabis Users

Predicting Treatment Response to Stimulants in Adult ADHD Using Functional Magnetic Resonance Imaging

Allocentric Memory in MS and Resting State Functional MRI

Angio-IMR and Cardiac MR-derived MVO in STEMI Patients

Characterization of Phenotypic and Genotypic Regressors for Imaging

Neurobiological Mechanisms of Stress in Youth With Chronic Widespread Pain

An fMRI Study of Treatment Optimization Comparing Two Disease Modifying Therapies Used to Treat Relapsing Remitting Multiple Sclerosis

MRI Study of Noninvasive Transcranial Electrical Stimulation in Tinnitus

Neural Effects of Mindfulness Training on Attention

An fMRI Investigation of the Effects of IV Lidocaine on Tinnitus

Development of Magnetic Resonance Imaging Techniques for Studying Mood and Anxiety Disorders

Photobiomodulation to Improve Cognition in TBI, With fMRI

Multifocal HD-tDCS and Motor Function

fMRI-neuronavigated rTMS Treatment for Symptoms of Depression Associated With Concussive TBI in the Military Population

A Study of Tirzepatide in Overweight and Very Overweight Participants

Imaging Biomarkers of Pancreatic Function and Disease

Adolescence, Puberty, and Emotion Regulation

HT-3951 vs. Placebo in Stroke Rehabilitation

Neuroimaging and Biomarkers in Chronic Visceral Pain

Neural Mechanisms of Mindfulness-based Cognitive Therapy (MBCT) for Posttraumatic Stress Disorder (PTSD)_VA Only

Cardiac 3D MRI in Pediatric Cancer Patients